Osteoporosis in AS patients is mediated by pro-inflammatory cytokines, such as TNF alpha, Il-17, Il-1, which activate osteoclastogenesis by overexpressing the RANKL [2,19]. This evidence concerns the gene IL17A and osteoporosis.